AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Discover the reasons behind Stubborn Scabs in Nose Causes, Remedies, Bloody & Those that Won’t Go Away, and get effective treatment tips.

Two Utah sisters have each had their entire stomach removed as a preventive measure to spare painful, cancer-filled future ...

If you struggle with snoring or find it difficult to sleep next to someone who does, a spoonful of honey before bed may help.

Insmed invests heavily in a robust pipeline with multi-billion potential, positioning for future growth. Check out why INSM ...

The biopharmaceutical industry is positioned for continued recovery, driven by recent FDA approvals and billion-dollar ...

ANSWER: This common problem is called solar purpura, and it is largely the sun causing the damage to the skin, thinning it ...

Q1 2025 Earnings Conference Call April 29, 2025 6:45 AM ETCompany ParticipantsAndy Barnett - Head of IRPascal Soriot ...

This common problem is called solar purpura, and it is largely the sun causing the damage to the skin, thinning it with age.

Learn more about whether Alvotech or Kymera Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, ...

This common problem is called solar purpura, and it is largely the sun causing the damage to the skin, thinning it with age.